5 Results for "

endocannabinoid uptake

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "endocannabinoid uptake" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-10865
CAS No.: 874902-19-9
Purity:  98.01%
Target:  

FAAH Autophagy

Research Areas:  

Neurological Disease

LY2183240 is a highly potent blocker of anandamide uptake (IC50= 270 pM; Ki=540 nM). LY2183240 is a potent, covalent inhibitor of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) with an IC50 of 12.4 nM. LY2183240 inactivates FAAH by carbamylation of the enzyme's serine nucleophile. LY2183240 also inhibits several other brain serine hydrolases with IC50s of 5.3, 0.09, 8.2 nM for MAG lipase, bh6 and KIAA1363, respectively .
loading...
    loading...
Cat. No.: HY-148940
CAS No.: 140670-40-2
Purity:  ≥99.0%
Target:  

Cannabinoid Receptor

Research Areas:  

Inflammation/Immunology

Docosahexaenoyl glycerol is an analog of endocannabinoid, which stimulates the glucose uptake and exhibits anti-inflammatory efficacy .
loading...
    loading...
Cat. No.: HY-103341
CAS No.: 390824-20-1
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of Anandamide .
loading...
    loading...
Cat. No.: HY-103338
CAS No.: 251908-92-6
Target:  

Others

Research Areas:  

Neurological Disease

AM1172 is metabolically stable anandamide uptake inhibitor. AM1172 inhibits [ 3H] anandamide transport in rat cortical neurons and human CCF-STTG1 astrocytoma cells with IC50 values of 2.1 μM and 2.5 μM, respectively. AM1172 can significantly inhibit AEA hydrolysis and concurrently decrease AEA uptake. AM1172 can be used for the study of endocannabinoid system regulation .
loading...
    loading...
Cat. No.: HY-10865R
CAS No.: 874902-19-9
Research Areas:  

Neurological Disease

LY2183240 (Standard) is the analytical standard of LY2183240 (HY-10865). This product is intended for research and analytical applications. LY2183240 is a highly potent blocker of anandamide uptake (IC50= 270 pM; Ki=540 nM). LY2183240 is a potent, covalent inhibitor of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) with an IC50 of 12.4 nM. LY2183240 inactivates FAAH by carbamylation of the enzyme's serine nucleophile. LY2183240 also inhibits several other brain serine hydrolases with IC50s of 5.3, 0.09, 8.2 nM for MAG lipase, bh6 and KiAA1363, respectively .
loading...
    loading...